POLAR - Polypharmacy, Drug Interactions, Risks

Motivation:

The overarching Use Case of the Medical Informatics Initiative (MI-I) „POLypharmacy, Drug interActions, Risks” aims to contribute to the detection of health risks in patients with polymedication using methods and processes from the MI-I.

Description:

The aim of the project is to use methods and processes of the Medical Informatics Initiative (MII) to contribute to the detection of health risks in patients with polypharmacy. Polypharmacy occurs especially in elderly patients with multimorbidity. Polypharmacy associated with an increased risk for medication errors and drug-drug or drug-disease interactions, which either reduce or intensify the desired effect of individual active substances or lead to undesired adverse drug effects (ADE). In the light of the aging population, potentially inappropriate medications (PIMs), which should be avoided in patients due to an unfavourable risk/benefit-ratio, represent an additional risk factor. Thus, POLAR focusses on the detection and prevention of medication-related problems in an interdisciplinary approach that creates a health IT infrastructure capable of supporting IT-based medication therapy safety across different health-IT consortia

Programme: MII - Medical Informatics Initiative

LHA ID: 83F28HCE9N-6

Public web page: https://www.medizininformatik-initiative.de/en/POLAR

Human Diseases: No Human Disease specified

Leipzig Health Atlas PALs: No PALs for this Project

Project Coordinators: Judith Schuster

Project created: 14th Aug 2020

Project Hierarchy

Related items

Powered by
(v.1.12.0-master)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

By continuing to use this site you agree to the use of cookies